Compare Enveric Biosciences Inc (ENVB) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Verisign, Inc. — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Verisign, Inc. trades at $287.62 (market cap $26.00B). The key difference: Verisign, Inc. is far larger — about 4193.5× Enveric Biosciences Inc's market cap, and Verisign, Inc. pays a 1.13% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | VRSN | |
|---|---|---|
Market Cap | $6.20M | $26.00B |
Sector | Health | Technology |
52-Week High | $17.40 | $310.00 |
52-Week Low | $1.27 | $211.49 |
Enterprise Value | $1.30M | $27.31B |
Dividend Yield | — | 1.13% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
